Cassava Sciences, Inc. - Common Stock (NQ:SAVA)

2.380 UNCHANGED

Last Price Updated: 4:00 PM EDT, Mar 10, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Cassava Sciences, Inc. - Common Stock

< Previous 1 2

...

18 19 20 21 22 23 24 25 26

...

38 39 Next >

Benzinga's Daily Brief On Trending Tickers For Feb. 11, 2022: Cassava Sciences, Cleveland Cliffs, GameStop, and More ↗

February 11, 2022

Benzinga’s “Daily Brief On Trending Tickers” highlights top-searched tickers from around the web and uses the Benzinga Pro platform to highlight recent news...

Via Benzinga

$1000 Invested In This Stock 5 Years Ago, Would Be Worth This Much ↗

February 11, 2022

Cassava Sciences (NASDAQ:SAVA) has outperformed the market over the past 5 years by 53.42% on an annualized basis.

Via Benzinga

Cassava Sciences Whale Trades Spotted ↗

February 09, 2022

Someone with a lot of money to spend has taken a bullish stance on Cassava Sciences (NASDAQ:SAVA). And retail traders should know. We noticed this today when the big position showed up on publicly...

Via Benzinga

Does Cassava Sciences and Its Alzheimer’s Drug Really Have What It Takes? ↗

February 08, 2022

Can Cassava Sciences' Simufilam drug really treat Alzheimer's? Who really knows. SAVA stock is pure speculation either way.

Via InvestorPlace

Keep an Eye on $60 as a Target Price for Cassava Sciences ↗

February 07, 2022

As long as you're using a moderate position size, it's fine to hold SAVA stock as it has a tendency to move fast and far from time to time.

Via InvestorPlace

This Is What Whales Are Betting On Cassava Sciences ↗

February 01, 2022

Someone with a lot of money to spend has taken a bearish stance on Cassava Sciences (NASDAQ:SAVA). And retail traders should know. We noticed this today when the big position showed up on publicly...

Via Benzinga

5 Short Squeeze Candidates To Watch: Vinco Ventures, TSR Inc, Biofrontera And More ↗

February 07, 2022

Potential short squeeze plays gained steam in 2021, with new retail traders looking for the next huge move. A short squeeze can occur when a heavily shorted stock rises in value instead of falling....

Via Benzinga

The End Result May Be Worth the Wait With Cassava Sciences Stock ↗

February 03, 2022

SAVA stock will continue to trade sideways until the moment of truth arrives for its drug candidate Simufilam.

Via InvestorPlace

Short Squeeze Activity: New Players, Same Game, Different Results ↗

February 01, 2022

Short squeezes will remain a big story in the financial news media until heavily shorted stocks that have been pushed up by individual investors come crashing back to earth.

Via Talk Markets

10 Health Care Stocks Whale Activity In Today's Session ↗

February 01, 2022

This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity...

Via Benzinga

Cassava Sciences Is an Exciting Roll-the-Dice Biotech Trade ↗

January 24, 2022

Take a wild ride -- but keep your position size small, please -- as SAVA stock could return to all-time highs or plummet to new depths soon.

Via InvestorPlace

Top Ideas in the Small Cap Biotech Space (LEXTF, ABBV, SAVA, SNDL, RETA, PAHC)

January 24, 2022

Via AB Newswire

Canadian Biotech Disruptor Lexston Life Sciences is unlocking the God Molecule (LEXTF, ICPT, AKBA, QURE, BNTX, SAVA)

January 19, 2022

Via AB Newswire

Topics Bonds Stocks

Cassava Sciences Stock Is Still Risky but Has Plenty of Upside Potential ↗

January 18, 2022

Among the plethora of high-risk, speculative, clinical-stage biotech plays out there, SAVA stock is one of the better bets out there.

Via InvestorPlace

10 Health Care Stocks Whale Activity In Today's Session ↗

January 14, 2022

This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our...

Via Benzinga

Peering Into Cassava Sciences Inc's Recent Short Interest ↗

January 10, 2022

Cassava Sciences Inc's (NASDAQ:SAVA) short percent of float has risen 22.31% since last its last report. The company recently reported that it has 10.25 million shares sold short...

Via Benzinga

Cassava Sciences Stock Is Worth Almost 4x More After Adjusting for Risk ↗

January 10, 2022

Cassava Sciences stands to gain using probability methods. On a risk-adjusted basis, SAVA stock is worth 3.7 times more, despite its downside.

Via InvestorPlace

7 High Risk Stocks That Are Worth The Volatile Vibes ↗

January 10, 2022

These seven high risk stocks made wild moves in 2021, but still have the potential to rocket higher. All are full of both risk and reward.

Via InvestorPlace

10 Health Care Stocks Whale Activity In Today's Session ↗

January 05, 2022

This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our...

Via Benzinga

Global Alzheimer’s Disease Therapeutics Market Projected To Generate Revenue Of $9.97 Billion By 2028

January 04, 2022

Palm Beach, FL –January 4, 2022 – FinancialNewsMedia.com News Commentary – Alzheimer’s disease is a degenerative, progressive ailment that attacks the brain’s nerve cells, resulting in memory loss,...

Via FinancialNewsMedia

How Are The Shorts Feeling About Cassava Sciences Inc? ↗

December 31, 2021

Cassava Sciences Inc's (NASDAQ:SAVA) short interest has increased 22% since the last report. The company recently reported that it has 10 million shares sold short, which is...

Via Benzinga

7 of the Best Meme Stocks for 2022 to Buy Now ↗

December 30, 2021

Although the meme stocks phenomenon is sagging in popularity, these seven current and/or former Reddit favorites could make another "to the moon" move or two in 2022.

Via InvestorPlace

Cassava Sciences Whale Trades Spotted ↗

December 29, 2021

A whale with a lot of money to spend has taken a noticeably bearish stance on Cassava Sciences. Looking at options history for Cassava Sciences (NASDAQ:SAVA) we detected 12...

Via Benzinga

Investing In This Alzheimer’s Drug Maker Risky But Could Be Quite Rewarding ↗

December 28, 2021

Coming up with the medicine for Alzheimer's Disease can be really good for a company and although it might seem risky, with great risks come great rewards.

Via Talk Markets

(SAVA) - Analyzing Cassava Sciences Inc's Short Interest ↗

December 22, 2021

Cassava Sciences Inc's (NASDAQ:SAVA) short percent of float has fallen 26.17% since last its last report. The company recently reported that it has 8.38 million shares sold short...

Via Benzinga

NAKD Stock: Is the Naked Brand Reverse Stock Split Good or Bad? What Investors Are Saying ↗

December 22, 2021

Naked Brand (NAKD) stock is in the news today as investors react to the company's 15-for-one reverse stock split for Tuesday.

Via InvestorPlace

Here's How Much $1000 Invested In Cassava Sciences 5 Years Ago Would Be Worth Today ↗

December 22, 2021

Cassava Sciences (NASDAQ:SAVA) has outperformed the market over the past 5 years by 41.64% on an annualized basis. Buying $1,000 In SAVA: 5 years ago, an investor could have...

Via Benzinga

SAVA Stock Alert: What Is Going on With Red-Hot Cassava Sciences Today? ↗

December 21, 2021

Biotech company Cassava saw a big jump today on positive news related to its Alzheimer's disease treatment. Keep an eye on SAVA stock.

Via InvestorPlace

55 Biggest Movers From Yesterday ↗

December 22, 2021

Gainers Reliance Global Group, Inc. (NASDAQ: RELI) shares jumped 78.7% to close at $5.45 on Tuesday after gaining around 6% on Monday. Biofrontera Inc. (NASDAQ: BFRI) gained 44.8...

Via Benzinga

Science Journal Finds No Evidence To Data Manipulation By Cassava Sciences' In 2005 Publication ↗

December 21, 2021

Cassava Sciences Inc (NASDAQ: SAVA) has been informed by the Neuroscience journal that there is no evidence to support claims of data manipulation in a 2005 paper authored by...

Via Benzinga

< Previous 1 2

...

18 19 20 21 22 23 24 25 26

...

38 39 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.